01 March 2006
Glutathione metabolism of filarial worms: A vulnerable target for the designand synthesis of new antifilarial agents.Sapna Gupta, Arvind Kumar Srivastava
Med Sci Monit 2006; 12(3): HY1-9 :: ID: 447100
The main problem regarding the chemotherapy of filariasis is that no safeand effective drug is available yet to combat the adult human filarial worms. One of the main reasonsis the prolonged existence, i.e. survival of filarial worms in mammalian hosts for many years, and havinga very strong antioxidant system. Glutathione (GSH) has been identified as an important part of the antioxidantsystem of many, if not all, living cells and, together with glutathione reductase (GR), it maintainsthe correct intracellular redox balance. It protects the cell against oxidative damage by non-enzymaticscavenging of free radicals and by enzymatic neutralization of toxic hydrogen peroxide, lipid hydroperoxides,and derivatives by glutathione-dependent peroxidases (GPXs) and glutathione-S-transferases (GSTs). Workin this direction reveals that filarial worms can synthesize and recycle GSH, and its depletion may beuseful in chemotherapeutic situations in which the cells to be killed and the cells to be spared havesubstantially different quantitative requirements for GSH. All normal mammalian cells have a considerableamount of GSH, whereas filarial worms may have GSH concentrations close to that required for their survivaland, therefore, a little manipulation of the glutathione metabolism of filarial worms may have drasticconsequences. The present review details the application of the glutathione metabolism of filarial wormsas a target for the design and synthesis of new antifilarial agents.
Keywords: Filaricides - chemistry, Filariasis - drug therapy, Antioxidants - metabolism, Filarioidea - metabolism, Glutamate-Cysteine Ligase - metabolism, Glutathione - metabolism, Glutathione Peroxidase - metabolism, Glutathione Reductase - metabolism, Glutathione Transferase - metabolism, Models, Biological
01 February 2023 : EditorialEditorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread
Med Sci Monit 2023; 29:e939580
19 January 2023 : Clinical ResearchEvaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...
Med Sci Monit In Press; DOI: 10.12659/MSM.938892
19 January 2023 : Clinical ResearchDetermining the Impact of the COVID-19 Pandemic on Dental Care in the Serbian Adult Population: An Online Q...
Med Sci Monit 2023; 29:e939238
27 December 2022 : Clinical ResearchEffect of Physiotherapy to Correct Rounded Shoulder Posture in 30 Patients During the COVID-19 Pandemic in ...
Med Sci Monit 2022; 28:e938926
01 Feb 2023 : Clinical ResearchComparison of 3 Enzyme-Linked Immunoassay Methods to Evaluate Serum Concentrations of Infliximab and Antibo...
Med Sci Monit In Press; DOI: 10.12659/MSM.939084
31 Jan 2023 : Clinical ResearchBalloon Dilation Eustachian Tuboplasty Combined with Tympanotomy Tube Insertion for Treatment of Refractory...
Med Sci Monit In Press; DOI: 10.12659/MSM.938879
31 Jan 2023 : Clinical ResearchComparison of Vision Correction and Corneal Thickness at 180-Day Follow-Up After Femtosecond Laser-Assisted...
Med Sci Monit In Press; DOI: 10.12659/MSM.939099
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292